Dovitinib assessed in HER2- breast cancer stratified by FGFR1 and HR amplification statuses Sep. 19, 2011
Oncothyreon obtains license to anticancer agents from Sanford-Burnham Medical Research Institute Sep. 15, 2011
RSS